Evidence map›Paper›PMID 36647211›Full record

ArticleIET nanobiotechnology2023

Optically driven microtools with an antibody-immobilised surface for on-site cell assembly.

Shuntaro Mori, Takumi Ito, Hidekuni Takao, Fusao Shimokawa, Kyohei Terao

Open access · goldAbstract read
In one paragraph

Article in IET nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Light force-powered cellular medical micromachines.Frontiers in bioengineering and biotechnology · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shuntaro MoriDepartment of Intelligent Mechanical Systems Engineering, Kagawa University, Takamatsu, Japan.
Takumi ItoDepartment of Intelligent Mechanical Systems Engineering, Kagawa University, Takamatsu, Japan.ORCID https://orcid.org/0000-0001-8491-3728
Hidekuni TakaoDepartment of Intelligent Mechanical Systems Engineering, Kagawa University, Takamatsu, Japan.
Fusao ShimokawaDepartment of Intelligent Mechanical Systems Engineering, Kagawa University, Takamatsu, Japan.
Kyohei TeraoDepartment of Intelligent Mechanical Systems Engineering, Kagawa University, Takamatsu, Japan.
Kagawa University · JP

Funding

Japan Science and Technology Agency JPMJFR212DJapan Society for the Promotion of Science 20H02118Ministry of Education, Culture, Sports, Science and TechnologyNakatani Foundation for Advancement of Measuring Technologies in Biomedical EngineeringPrecursory Research for Embryonic Science and Technology JPMJPR14FB
6 · The paper itself

Abstract

To enable the accurate reproduction of organs in vitro, and improve drug screening efficiency and regenerative medicine research, it is necessary to assemble cells with single-cell resolution to form cell clusters. However, a method to assemble such forms has not been developed. In this study, a platform for on-site cell assembly at the single-cell level using optically driven microtools in a microfluidic device is developed. The microtool was fabricated by SU-8 photolithography, and antibodies were immobilised on its surface. The cells were captured by the microtool through the bindings between the antibodies on the microtool and the antigens on the cell membrane. Transmembrane proteins, CD51/61 and CD44 that facilitate cell adhesion, commonly found on the surface of cancer cells were targeted. The microtool containing antibodies for CD51/61 and CD44 proteins was manipulated using optical tweezers to capture HeLa cells placed on a microfluidic device. A comparison of the adhesion rates of different surface treatments showed the superiority of the antibody-immobilised microtool. The assembly of multiple cells into a cluster by repeating the cell capture process is further demonstrated. The geometry and surface function of the microtool can be modified according to the cell assembly requirements. The platform can be used in regenerative medicine and drug screening to produce cell clusters that closely resemble tissues and organs in vivo.

Indexed as

Microfluidic Analytical TechniquesAntibodiesCell AdhesionCell MembraneHeLa CellsHumansAntibodiesbioMEMSlaser beam applicationsmicrochannel flowmicrofabrication

Identifiers

PMID36647211
PMCPMC10190638
OpenAlexW4316669486

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.